InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | 2026-03-19 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sale | 5,363 | $25.96 | $139K | 105.4K | View ↗ | |
| 2026-03-17 | 2026-03-19 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sale | 304 | $28.15 | $9K | 110.7K | View ↗ | |
| 2026-03-17 | 2026-03-19 | Waters Kevin | EVP, CFO | Sale | 706 | $28.15 | $20K | 151.6K | View ↗ | |
| 2026-03-10 | 2026-03-12 | Nouri Alaleh | EVP, CLO, CORP. SEC. | Sale | 3,243 | $25.65 | $83K | 111.0K | View ↗ | |
| 2026-03-09 | 2026-03-09 | Desai Antal Rohit | Director | Purchase | 98.7K | $24.55 | $2.42M | 426.3K | View ↗ |
No annual data found.
How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance Reset
PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
Procept (PRCT) Q1 2026 Earnings Transcript